|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
|
|---|---|---|
| Operating expenses: | ||
| Research and development | ||
| General and administrative | ||
| Total operating expenses | ||
| Operating loss | ||
| Interest and investment income | ||
| Net loss | ||
| Unrealized gain (loss) on marketable securities | ||
| Total other comprehensive gain (loss) | ||
| Total comprehensive loss | ||
| Share information: | ||
| Net loss per share attributable to common stockholders, basic (in dollars per share) | ||
| Net loss per share attributable to common stockholders, diluted (in dollars per share) | ||
| Weighted-average shares of common stock outstanding, basic (in shares) | ||
| Weighted-average shares of common stock outstanding, diluted (in shares) |
Loading...
